1 / 3

U.S. Sucralfate Market Shows Rapid Growth And Development In Pharma, Medical, Medical & Biotech Industries

Sucralfate is a hydroxy aluminum salt of sucrose octasulfate that functions as a local mucosal adherent.<br>

rushi12
Download Presentation

U.S. Sucralfate Market Shows Rapid Growth And Development In Pharma, Medical, Medical & Biotech Industries

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. U.S. Sucralfate Market - Size, Share, Growth, U.S. Sucralfate Market - Size, Share, Growth, Outlook, and Opportunity Analysis, 2018-2026 Outlook, and Opportunity Analysis, 2018-2026 Sucralfate is a hydroxy aluminum salt of sucrose octasulfate that functions as a local mucosal adherent. It forms a coating over ulcers by sticking to the affected area, which protects the area from acid and enzymes and helps ulcers to heal more quickly. Sucralfate can also be used in treating ulcers and upper gastrointestinal disorders of dog, horse, and cat, which may arise due to drugs (particularly non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids), toxic chemical ingestion, liver disease, renal failure, carcinoma, stress (trauma, shock, sepsis, and burns), and inflammatory bowel disease. Request Sample Copy of Research Report: https://www.coherentmarketinsights.com/insight/request-sample/2975 Increasing clinical trials for exploring different uses of sucralfate for different indications is a major factor driving U.S. sucralfate market growth. For instance, according to the study published by the National Center of Biotechnology Information, in 2016, a clinical trial conducted on Radiation Proctitis patients receiving sucralfate treatment showed 92.3% positive results in 16 weeks. Increasing prevalence of gastrointestinal disorders and H. pylori-associated infections is expected to propel the market growth Rising incidence of gastric ulcers caused due to use of nonsteroidal anti-Inflammatory drugs (NSAID) and H. pylori infection is expected to drive the U.S. sucralfate market. According to the study by Deccan College of Medical Sciences, 2016, an estimated 95% of duodenal and 70% of gastric ulcers are caused due to Helicobacter pylori. Furthermore, the same study also stated that around 14-25% of gastric and duodenal ulcers are associated with NSAID use. Rising prevalence of peptic ulcers is expected to bolster the market growth. According to the data published by ScienceDirect Journal in 2016, duodenal ulcers are more common type of peptic ulcers and its prevalence was around 6% to 12% in the U.S.

  2. Report includes chapters which deeply display the following deliverable about industry : • U.S. Sucralfate Market Research Objective and Assumption • U.S. Sucralfate Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • U.S. Sucralfate Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global U.S. Sucralfate Market, By Regions • U.S. Sucralfate Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • U.S. Sucralfate Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • U.S. Sucralfate Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • U.S. Sucralfate Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion Key Players Major players operating in the U.S. sucralfate market include Teva Pharmaceutical Industries Ltd., Allergan plc, Vertice Pharma LLC, and Pharmaceutical Associates Inc. Inquire Here Before Purchase: https://www.coherentmarketinsights.com/insight/talk-to-analyst/2975 Detailed Segmentation: U.S. Sucralfate Market, By Formulation: • Tablet • Liquid Suspension • Unit Dose Cup • Bottle •

  3. U.S. Sucralfate Market, By Indication: • Gastric Ulcers • Duodenal Ulcers • Gastro Esophageal Reflux Disease (GERD) • Others U.S. Sucralfate Market, By Distribution Channel: • Hospital Pharmacy • Retail Pharmacy • Online Pharmacy U.S. Sucralfate Market, By State: • Illinois • • • About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: sales@coherentmarketinsights.com

More Related